我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

中草药对低氧性肺动脉高压的保护性作用、相关机制及研究进展

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2016年第1期
页码:
102-106
栏目:
综述
出版日期:
2015-09-15

文章信息/Info

Title:
Protective effects, mechanism and research progress of Chinese herbal medicine in hypoxic pulmonary hypertension
作者:
魏毅涛1; 段 炼1; 王 晋2; 刘曼玲3; 赵澎涛3
（第四军医大学：1.学员一旅四营十五连，2.预防医学系放射医学教研室，3.基础部病理生理学教研室，陕西 西安 710032）
Author(s):
WEI Yi-tao1;  DUAN Lian1;  WANG Jin2;  LIU Man-ling3;  ZHAO Peng-tao3
(1.Company 15, Battalion 4, Brigade 1, 2.Department of Radiation Medicine, School of Military Preventive Medicine, 3.Department of Pathophysiology, School of Basic Medical Sciences, Fourth Military Medical University, Xi'an 710032, Shaanxi, China)
关键词:
低氧性肺动脉高压; 丹参酮IIA; 红景天苷; 氧化苦参碱; 白藜芦醇; 小檗碱
Keywords:
hypoxic pulmonary hypertension;  tanshinone IIA;  salidroside;  oxymatrine;  resveratrol;  berberine
分类号:
R543.2
DOI:
-
文献标识码:
A
摘要:
低氧性肺动脉高压是临床上的一种常见疾病，发病率和死亡率较高。动物实验研究表明一些常见的中草药对低氧性肺动脉高压具有良好的的防治作用。本文将对其保护作用机制及研究进展进行综述。
Abstract:
Hypoxic pulmonary hypertension is a common clinical disease with high morbidity and mortality. Animal studies have shown that some common Chinese herbs play an important role in preventing hypoxic pulmonary hypertension. This article summarizes the protective mechanisms and research progress related to these Chinese herbs.

参考文献/References

[1]Schermuly RT,Ghofrani HA,Wilkins MR,et al.Mechanisms of disease: pulmonary arterial hypertension[J].Nat Rev Cardiol,2011,8(8):443-455.
[2]Moudgil R,Michelakis ED,Archer SL.Hypoxic pulmonary vasoconstriction[J].J Appl Physiol(1985),2005,98(1):390-403.
[3]Leon-Velarde F,Villafuerte FC,Richalet JP.Chronic mountain sickness and the heart[J].Prog Cardiovasc Dis,2010,52(6):540-549.
[4]Bartelds B,van Loon RL,Mohaupt S,et al.Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension[J].Chest,2012,141(3):651-660.
[5]Zhang B,Niu W,Xu D,et al.Oxymatrine prevents hypoxia- and monocrotaline-induced pulmonary hypertension in rats[J].Free Radic Biol Med,2014,69:198-207.
[6]Perez-Vizcaino F,Cogolludo A,Moreno L.Reactive oxygen species signaling in pulmonary vascular smooth muscle[J].Respir Physiol Neurobiol,2010,174(3):212-220.
[7]Tucker A,Rhodes J.Role of vascular smooth muscle in the development of high altitude pulmonary hypertension: an interspecies evaluation[J].High Alt Med Biol,2001,2(2):173-189.
[8]Nelson MT,Quayle JM.Physiological roles and properties of potassium channels in arterial smooth muscle[J].Am J Physiol,1995:268(4 Pt 1):C799-C822.
[9]何建国,卢献灵.肺动脉高压发病机制的进展带来临床治疗的革命[J].中国循环杂志,2008,23(6):471-474.
[10]杨媛华,王 辰.肺动脉高压的发病机制及治疗进展[J].国外医学·呼吸系统分册,2004,24(5):323-325.
[11]张清友,杜军保.肺动脉高压的治疗现状与进展[J].临床儿科杂志,2010,28(7):607-610.
[12]Wu H,Li Y,Wang Y,et al.Tanshinone IIA Attenuates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/ Angiotensin-(1-7) Axis in Rats[J].International Journal of Medical Sciences,2014,11(6):578-586.
[13]Zhou L,Zuo Z,Chow MS.Danshen:an overview of its chemistry,pharmacology,pharmacokinetics,and clinical use[J].J Clin Pharmacol2005,45(12):1345-1359.
[14]Cheng TO.Cardiovascular effects of Danshen[J].Int J Cardiol,2007,121(1):9-22.
[15]Zheng L,Liu M, Wei M,et al.Tanshinone IIA attenuates hypoxic pulmonary hypertension via modulating KV currents[J].Respiratory Physiology & Neurobiology,2015,205:120-128.
[16]Wang J,Dong M,Liu M,et al.Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats[J].European Journal of Pharmacology,2010,640(1-3):129-138.
[17]Wang J, Weigand L,Wang W,et al.Chronic hypoxia inhibits Kv channel gene expression in rat distal pulmonary artery[J].Am J Physiol Lung Cell Mol Physiol,2005,288(6):L1049-L1058.
[18]Filippatos G,Tilak M,Pinillos H,et al.Regulation of apoptosis by angiotensin II in the heart and lungs(Review)[J].Int J Mol Med,2001,7(3):273-280.
[19]Ferrario CM.Angiotensin-converting enzyme 2 and angiotensin-(1-7):an evolving story in cardiovascular regulation[J].Hypertension,2006,47(3):515-521.
[20]Pak O,Aldashev A,Welsh D,et al.The effects of hypoxia on the cells of the pulmonary vasculature[J].Eur Respir J,2007,30(2):364-372.
[21]Yu L,Quinn DA,Garg HG,et al.Gene expression of cyclin-dependent kinase inhibitors and effect of heparin on their expression in mice with hypoxia-induced pulmonary hypertension[J].Biochem Biophys Res Commun,2006,345(4):1565-1572.
[22]Toyoshima H,Hunter T.p27,a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21[J].Cell,1994,78(1):67-74.
[23]Slingerland J,Pagano M.Regulation of the cdk inhibitor p27 and its deregulation in cancer[J].J Cell Physiol,2000,183(1):10-17.
[24]Carrano AC,Pagano M.Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression[J].J Cell Biol,2001,153(7):1381-1390.
[25]Luo Y,Xu DQ,Dong HY,et al.Tanshinone IIA Inhibits Hypoxia-Induced Pulmonary Artery Smooth Muscle Cell Proliferation via Akt/Skp2/ p27-Associated Pathway[J].PLoS One,2013,8(2):e56774.
[26]肖 妤，李绍平，王一涛，等.红景天苷药理研究进展[J].实用医院临床杂志,2006,3(3):98-99.
[27]黄晓颖.腺苷A2a受体在红景天苷调节大鼠低氧性肺动脉高压中的作用[J].中国病理生理杂志,2012,28(12):2135-2140.
[28]赵贺玲，林树新，贾 斌，等.红景天甙抑制兔缺氧性肺动脉平滑肌细胞增殖的作用[J].第四军医大学学报,2000,21(02):186-189.
[29]于洪伟，季宇彬，汲晨锋.高山红景天对外周性疲劳大鼠骨骼肌细胞内ATP、AMP以及Pi含量的影响[J].江西中医药,2009,40(11):73-74,56.
[30]徐敦全.雌激素减轻大鼠低氧性肺动脉高压的作用及机制研究[D].西安:第四军医大学,2014.
[31]冯恩志，郭振援，杨生岳，等.红景天对高原慢性肺心病患者肺动脉压的影响及其作用机制[J].中华保健医学杂志,2010,12(4):261-263.
[32]赵贺玲，林树新，李 剑.红景天甙对缺氧状态下鼠肺动脉平滑肌细胞增殖和〔Ca2+〕i的影响[J].解放军预防医学杂志,2004,22(4):259-262.
[33]包玉羡.氧化苦参碱的药理作用与临床应用[J].世界最新医学信息文摘,2014,14(6):96-98.
[34]牛 雯.氧化苦参碱对低氧性肺动脉高压的防治作用及其机制研究[D].西安:第四军医大学,2014.
[35]刘 斌，彭 军.氧化应激和肺动脉高压血管重构[J].中国动脉硬化杂志,2011,19(6):539-542.
[36]Kobayashi A,Ohta T,Yamamoto M.Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes[J].Methods Enzymol,2004,378:273-286.
[37]杨宝军，王倩倩.内皮一间质转化参与组织纤维化的研究进展[J].医学综述,2013,19(21):3856-3859.
[38]谭永丽.低氧诱导猪肺动脉内皮细胞间质转化的鉴定及其生物学意义[J].中国呼吸与危重监护杂志,2013,12(4):398-403.
[39]Baur JA,Sinclair DA.Therapeutic potential of resveratrol:the in vivo evidence[J].Nat Rev Drug Discov,2006,5(6):493-506.
[40]Lan J,Zhao Y,Dong F,et al.Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus,hyperlipemia and hypertension[J].J Ethnopharmacol,2015,161:69-81.
[41]Xiao M,Men LN,Xu MG,et al.Berberine protects endothelial progenitor cell from damage of TNF-alpha via the PI3K/AKT/eNOS signaling pathway[J].Eur J Pharmacol,2014,743:11-16.
[42]陈少萍，陈少慈.小檗碱对肺动脉平滑肌细胞增殖的影响[J].汕头大学医学院学报,2008,21(2):78-82.
[43]Ma L,Zhang L,Wang B,et al.Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9via PI3K[J].Eur J Pharmacol,2015,755:102-109.

备注/Memo

备注/Memo:
收稿日期：2015-04-23.
>基金项目：国家自然科学基金项目资助（81200036，81471816，81270328）
通讯作者：赵澎涛，讲师，主要从事呼吸与循环系统疾病病理生理学研究 Email:zhaopt@fmmu.edu.cn
作者简介：魏毅涛，本科生 Email:307817731@qq.com
更新日期/Last Update: 2015-09-16